Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
1.930
-0.320 (-14.22%)
At close: Mar 31, 2025, 4:00 PM
1.940
+0.010 (0.52%)
After-hours: Mar 31, 2025, 7:40 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $211.74 million as of March 31, 2025. Its market cap has decreased by -51.73% in one year.
Market Cap
211.74M
Enterprise Value
-71.31M
1-Year Change
-51.73%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since July 24, 2020, Annexon's market cap has decreased from $639.51M to $211.74M, a decrease of -66.89%. That is a compound annual growth rate of -21.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 211.74M | -61.28% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | 955.09M | 49.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |